Next Article in Journal
Resistance Testing for the Treatment of Chronic Hepatitis C with Direct Acting Antivirals: When and for How Long?
Previous Article in Journal
Enterococcal Meningitis in Association with Strongyloides Hyperinfection Syndrome
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Consensus Statement on the Management of Patients with HCV Infection in Romania

by
Consensus Statement on HCV Infection in Romania Working Group
GERMS 2017, 7(1), 32-39; https://doi.org/10.18683/germs.2017.1106
Submission received: 1 February 2017 / Revised: 26 February 2017 / Accepted: 28 February 2017 / Published: 1 March 2017

Abstract

Background: HCV direct-acting antivirals (DAAs) have made treatment easier for both patients and healthcare practitioners, but have also brought new challenges in terms of patient management and monitoring prior to, during, and after treatment. Methods: To sum up and unify the clinical experience of Romanian DAA prescribing physicians, we have organized a Consensus Meeting in November 2016 in Bucharest, Romania. Consensus Statement: The Consensus Meeting has provided expert answers to ten significant questions regarding HCV infection, namely: How do we diagnose patients with HCV infection? How do we stage liver disease in patients with HCV infection? How do we monitor patients with HCV infection prior to treatment? Which patients with HCV infection do we treat? When do we start treatment for HCV infection? What regimens do we use for treating HCV infection? How do we monitor patients with HCV infection during treatment? What adverse events should we expect during treatment of HCV infection and how do we prevent/manage them? How do we monitor patients with HCV infection after treatment? How do we expect the landscape of HCV to change in the following years?
Keywords: HCV; DAA; treatment; monitoring; adverse events HCV; DAA; treatment; monitoring; adverse events

Share and Cite

MDPI and ACS Style

Consensus Statement on HCV Infection in Romania Working Group. Consensus Statement on the Management of Patients with HCV Infection in Romania. GERMS 2017, 7, 32-39. https://doi.org/10.18683/germs.2017.1106

AMA Style

Consensus Statement on HCV Infection in Romania Working Group. Consensus Statement on the Management of Patients with HCV Infection in Romania. GERMS. 2017; 7(1):32-39. https://doi.org/10.18683/germs.2017.1106

Chicago/Turabian Style

Consensus Statement on HCV Infection in Romania Working Group. 2017. "Consensus Statement on the Management of Patients with HCV Infection in Romania" GERMS 7, no. 1: 32-39. https://doi.org/10.18683/germs.2017.1106

APA Style

Consensus Statement on HCV Infection in Romania Working Group. (2017). Consensus Statement on the Management of Patients with HCV Infection in Romania. GERMS, 7(1), 32-39. https://doi.org/10.18683/germs.2017.1106

Article Metrics

Back to TopTop